Axon Enterprise, Inc. (AXON) Down 6.4% — Time to Reduce Exposure?

  • AXON fell 6.41% to $390.44 from $417.19 the previous trading day
  • Weiss Ratings assigns C- (Hold)
  • Market cap is $33.89B

Axon Enterprise, Inc. (AXON) endured a painful session on Friday, closing at $390.44 on the NASDAQ, a $26.75 decline from the prior close of $417.19. The selloff extends a long retreat for the stock, which now sits roughly 48.9% below its 52-week high of $764.02, set on October 28, 2025. Nearly a year later, the shares trade at about half that peak, and the market is still repricing what it will pay for Axon's growth.

Volume came in at 1,014,617 shares, slightly above the 90-day average of 992,064. Turnover was essentially normal despite the size of the decline.


Why Axon Enterprise, Inc. Price is Moving Lower

The most plausible driver of Friday's drop was a broad market and Industrials selloff, made worse by Axon's rich valuation. By mid-afternoon, the Nasdaq was down about 2% and the S&P 500 about 1%. Bloom Energy Corporation (BE) dropped 6.33%, nearly matching Axon's loss, and Vertiv Holdings Co (VRT) fell 3.88%. Axon was poorly positioned for that kind of session: as of October 7, the stock traded at a forward P/E of 42.61x, compared with 32.10x for its industry. That premium makes it one of the first places investors cut when they rotate out of expensive growth.

Analyst caution added to the pressure. On October 15, Raymond James lowered its price target to $675 from $800 while keeping an Outperform rating. The firm cited concerns around SaaS performance, acquisitions, and margins, and it expects a seasonally soft third quarter before a stronger fourth quarter. Raymond James noted that Axon's FY26 outlook was unchanged. Even so, a target cut that size from a supportive firm, landing the day before a sector-wide selloff, gave holders little reason to stay put. Axon also announced federal awards on October 15. These covered more than 22,000 cameras and evidence-management licenses, a DHS counter-drone contract, and over 1,600 TASER 10 devices for VA police. The wins were supportive, but they could not offset the macro pressure.

The margin worries Raymond James raised trace back to the most recent quarter. Axon's Q2 report on August 5 showed adjusted EPS of $1.88 against a $1.84 estimate. Revenue of $904.39 million beat the $876.42 million consensus and rose 35% year over year. Beneath those beats, however, profitability moved the wrong way. Adjusted EPS fell short of the $2.18 posted a year earlier, and Software & Services gross margin contracted 4.3 percentage points to 71.3%. With Q3 results expected around November 3, investors are weighing whether that compression continues, at a valuation that leaves little room for disappointment.


What is the Axon Enterprise, Inc. Rating - Should I Sell?

Weiss Ratings assigns AXON a C- rating. Current recommendation is Hold. A C- sits at the low end of Hold territory. It reflects a business with real financial strength, offset by stock performance and earnings quality that have not kept pace with the company's growth story.

The firmest support comes from the balance sheet. Axon is rated Excellent on the Solvency Index. That gives the company room to keep spending on acquisitions, product development, and its software platform without leaning on outside financing, which matters when analysts are already questioning acquisition costs. The Good rating on the Efficiency Index reflects a business model anchored by recurring software revenue. Software & Services gross margin held at 71.3% even after last quarter's compression. Still, a 6.22% ROE and a 6.19% profit margin show how much of that gross profit gets consumed by heavy investment, and they explain why the rating stops short of Excellent.

Where the picture becomes more nuanced is growth and returns. Axon is rated Fair on the Growth Index, a modest rating for a company that just grew revenue 35.28%. The gap lies in earnings: adjusted EPS slipped to $1.88 from $2.18 a year earlier, so the top line is expanding faster than profits can follow. The Fair Total Return Index reflects a stock that has given back nearly half its value since its October 2025 peak. The Weak rating on the Volatility Index is the clearest drag on the overall grade. Friday's 6.41% decline, driven by a market-wide flight from expensive tech names, shows how sharply a premium-multiple stock like Axon can swing when sentiment turns.

Within the Industrials sector, Axon trails Deere & Company (DE, C+), Vertiv Holdings Co (VRT, C+), and Northrop Grumman Corporation (NOC, C+). It also sits below Bloom Energy Corporation (BE, C), a fellow high-growth name that suffered a similar decline on Friday. In Weiss's framework, Axon offers a less favorable risk/reward balance than these peers for now.


About Axon Enterprise, Inc.

Axon Enterprise, Inc. (AXON) is an Industrials company that builds hardware, software, and cloud services for public safety. Founded in 1993 as TASER International and headquartered in Scottsdale, Arizona, the company first became known for its conducted energy weapons. It has since grown into a broad technology provider for law enforcement, corrections, federal agencies, the military, and private security customers in the United States and abroad. Its TASER line, led by the TASER 10, remains a core franchise. The company pairs these devices with Axon Body cameras and Axon Fleet in-car video systems.

The center of Axon's strategy is its software ecosystem, built around Axon Evidence (Evidence.com), a cloud platform for storing, managing, and sharing digital evidence. Around that platform, Axon has added records management, dispatch, real-time crime center tools, and AI-driven products such as Draft One, which helps officers generate report drafts from body camera audio. The company has also expanded into counter-drone and aerial technology, a market reflected in its recent DHS counter-drone contract. Much of this is sold through subscription bundles that combine devices, cloud storage, and software licenses into multi-year agreements.

Axon's competitive advantage comes from that integration. An agency that adopts Axon cameras, TASER devices, and evidence software ends up with a connected workflow that is costly and disruptive to replace. The arrangement creates high switching costs and steady recurring revenue. The company's scale with U.S. police departments and its expanding federal relationships give it a distribution edge that smaller rivals struggle to match. However, government procurement cycles, budget pressures, and the expense of continued acquisitions remain ongoing risks.


Investor Outlook

Axon Enterprise, Inc. (AXON) carries a Weiss Rating of C- (Hold). Its strong balance sheet and growing software business are offset by margin pressure, a premium valuation, and a stock trading nearly 49% below its high. Investors should watch Q3 report expected around November 3, focusing on whether Software & Services gross margin stabilizes and whether the stronger Q4 Raymond James expects begins to show up in guidance. See full rankings of all C- rated Industrials stocks inside the Weiss Stock Screener.

--

This Weiss Instant News Alert was compiled by narrative data technology, our proprietary ratings models and analysis by Weiss Ratings with the intent of providing our readers with the fastest research and independent coverage. Weiss Instant News Alerts have been reviewed by a member of our editorial staff before publication. Please send any questions or comments about this story to [email protected]
Top Tech Stocks
See All »
B
AAPL NASDAQ $352.45
B
MSFT NASDAQ $508.29
B
NVDA NASDAQ $150.96
Top Consumer Staple Stocks
See All »
B
WMT NASDAQ $127.36
B
Top Financial Stocks
See All »
B
A
JPM NYSE $324.11
B
V NYSE $415.22
Top Energy Stocks
See All »
B
CVX NYSE $205.88
B
COP NYSE $134.40
Top Health Care Stocks
See All »
B
LLY NYSE $1,382.75
B
JNJ NYSE $272.70
B
ABBV NYSE $286.01
Top Real Estate Stocks
See All »
B
PLD NYSE $125.22